WASHINGTON — The U.S. Defense Department is weighing a new search for immune-protein “cocktails” it hopes will protect humans against Ebola and other deadly, weapon-usable viruses.
The Pentagon two weeks ago invited scientists to submit research proposals for designing “monoclonal antibodies” that could protect against Ebola and Marburg, as well as “alphaviruses” such as Venezuelan equine encephalitis.
Pentagon planners have been turning to antibodies as a possible tool because “no easy and quick fix” for such agents has emerged from efforts to develop vaccines or traditional antiviral treatments, said Gigi Gronvall, a senior associate with the Center for Health Security at the University of Pittsburgh Medical Center.
The early-stage research now under consideration ideally would lead to single-shot treatments capable of guarding troops for months from multiple virus types, the Defense Threat Reduction Agency said in a Sept. 18 solicitation. DTRA officials welcomed researchers to propose “‘cocktails’ that may enable cross-protection against multiple species of virus.”
The emphasis on “cocktails” makes the latest DTRA proposal particularly notable, because several studies suggest that mixes of several antibodies can be particularly effective in fighting pathogens, Gronvall told Global Security Newswire in a telephone interview. Antibodies hit their targets with such specificity that a treatment with multiple immune proteins can help account for slight variations between invading microbes.
Monoclonal antibodies have been in use since the 1980s to treat cancer and immune-linked ailments such as rheumatoid arthritis, but their use against infectious pathogens has lagged, according to a DTRA-sponsored report co-authored by Gronvall on the technology’s biodefense potential.
The United States last year licensed the first inhalation anthrax treatment to use the technology, which involves creating massive quantities of a single immune “antibody.” The human body naturally generates such proteins, each of which is designed to mark a specific pathogen or toxin for elimination by other immune-system components.
One antibody cocktail grown in modified tobacco plants showed promising potency against Ebola infections specifically, according to a study published in August.
“There have been a lot of changes in the way that monoclonal antibody technologies have evolved over the last several years, and it makes monoclonal antibodies a very nice piece of their approach to medical countermeasures,” Gronvall said.
The latest DTRA Broad Agency Announcement seeks proposals for studies no longer than one year, with a cost no greater than $500 million. The filing deadline is Oct. 16.
What We're Following See More »
Beginning next month, Metro will begin a series of "about 15 separate large-scale work projects," each of which will close down stations and/or sections of track for up to weeks at a time. The entire initiative is expected to take about a year. The Washington Post has a list of the schedule of closures, and which lines and stations they'll affect.
A day after saying he could not yet support Donald Trump's presidential bid, House Speaker Paul Ryan has invited the billionaire to a meeting in Washington next week with House leadership. Ryan and Republican National Committee Chairman Reince Priebus will also meet separately with Trump.
"President Obama used the White House podium on Friday to dismiss Donald Trump as an unserious candidate to succeed him, and said leading the country isn't a job that's suited to reality show antics." At a briefing with reporters, the president said, "I just want to emphasize the degree to which we are in serious times and this is a really serious job. This is not entertainment. This is not a reality show. This is a contest for the presidency of the United States. And what that means is that every candidate, every nominee needs to be subject to exacting standards and genuine scrutiny."
In the The White House on Thursday night unveiled a series of executive actions to combat money laundering—"among the most comprehensive response yet to the Panama Papers revelations." The president's orders will tighten transparency rules, close loopholes that allow "foreigners to hide financial activity behind anonymous entities in the U.S., and demand stricter “customer due diligence” rules for banks.
The #NeverTrump movement is now mulling the idea of recruiting a candidate to run as an independent or under a third-party banner. But who might it be? The Hill offers a preliminary list.
- Sen. Ben Sasse (R-NE)
- Mitt Romney
- 2012 (and perhaps 2016) Libertarian candidate Gary Johnson
- Former Marine Gen. John Kelly
- Rep. Justin Amash (R-MI)
- Former Sen. Tom Coburn (R-OK)
- South Carolina Gov. Nikki Haley
- Sen. Rand Paul (R-KY)